The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Incorporating alternative investments into your long-term portfolio can enhance diversification and improve returns.
27,567 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A rocket-test explosion at Cape Canaveral spared critical launch-pad components, preserving a path back to flight for...
Bank of America reinstates Buy on Microsoft, guiding toward a $500 price target as Azure growth and Copilot adoption ...
As travel demand rebounds, investors want clarity on which cruise stock to buy in 2026. This guide contrasts Royal Ca...
Disney, McDonald’s, Microsoft, and Procter & Gamble now appear oversold despite solid earnings and durable consumer s...
A Friday announce could insert Marvell into the S&P 500 after a dramatic stock surge. The company's market cap dwarfs...
As the AI rally fans the markets, the boom looks like dot-com. Yet Bitcoin bulls point to a tangible edge—scarcity an...
A sweeping crypto downturn sparks roughly $1.2 billion in liquidations, as Ethereum tests key support under $1.7K and...
A sharp reversal in momentum stock leaders has sparked a broader market rotation. Traders weigh what comes next as vo...
Starbucks shows a credible turnaround with rising traffic and profits, while Chipotle contends with growth fatigue an...
A new hybrid crypto platform blends self-custody with real-world asset yields, aiming to unite TradFi and DeFi within...
In a crowded field of weekly pay ETFs, Roundhill’s lineup appears to deliver cash income more reliably, yet investors...